Suppr超能文献

治疗遗传性视网膜疾病所致黄斑新生血管的临床结局:文献综述。

Clinical outcomes of treated macular neovascularisation secondary to inherited retinal diseases: a literature review.

机构信息

St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK

St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.

出版信息

BMJ Open Ophthalmol. 2023 Jul;8(1). doi: 10.1136/bmjophth-2023-001309.

Abstract

Many inherited retinal diseases (IRD) can be associated with, or be secondarily complicated by, macular neovascularisation (MNV), which has been variably treated with intravitreal antivascular endothelial growth factor, steroids, laser and surgery. In this article, we aim to present a consolidated literature review of management of IRD-related MNV.

摘要

许多遗传性视网膜疾病(IRD)可伴有或继发黄斑新生血管(MNV),其治疗方法因血管内皮生长因子抑制剂、皮质类固醇、激光和手术等而异。本文旨在对与 IRD 相关的 MNV 的治疗进行综合文献回顾。

相似文献

2
Low power laser treatment of the retina ameliorates neovascularisation in a transgenic mouse model of retinal neovascularisation.
Exp Eye Res. 2009 Nov;89(5):791-800. doi: 10.1016/j.exer.2009.07.004. Epub 2009 Jul 16.
3
OCT-A characterisation of recurrent type 3 macular neovascularisation.
Br J Ophthalmol. 2021 Feb;105(2):222-226. doi: 10.1136/bjophthalmol-2020-316054. Epub 2020 Mar 30.
6
Characterisation of macular neovascularisation in geographic atrophy.
Br J Ophthalmol. 2022 Sep;106(9):1282-1287. doi: 10.1136/bjophthalmol-2021-318820. Epub 2021 Apr 9.
7
Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomes.
Eye (Lond). 2023 Jun;37(9):1758-1765. doi: 10.1038/s41433-022-02231-y. Epub 2022 Sep 14.
9
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Cochrane Database Syst Rev. 2020 Jul 7;7(7):CD009510. doi: 10.1002/14651858.CD009510.pub3.

本文引用的文献

1
Clinical findings in eyes with BEST1-related retinopathy complicated by choroidal neovascularization.
Graefes Arch Clin Exp Ophthalmol. 2022 Apr;260(4):1125-1137. doi: 10.1007/s00417-021-05447-y. Epub 2021 Oct 18.
2
Treatment and longitudinal follow-up of CNV associated with pattern dystrophy with novel variant.
Ophthalmic Genet. 2021 Dec;42(6):768-772. doi: 10.1080/13816810.2021.1952617. Epub 2021 Sep 5.
5
OCT-angiography assessing quiescent and active choroidal neovascularization in retinitis pigmentosa associated with pathogenic variant.
Eur J Ophthalmol. 2022 Jul;32(4):NP98-NP102. doi: 10.1177/11206721211004396. Epub 2021 Mar 18.
6
OCT angiography for the diagnosis and management of choroidal neovascularization secondary to choroideremia.
Am J Ophthalmol Case Rep. 2021 Feb 25;22:101042. doi: 10.1016/j.ajoc.2021.101042. eCollection 2021 Jun.
8
Incidence and Natural History of Retinochoroidal Neovascularization in Enhanced S-Cone Syndrome.
Am J Ophthalmol. 2021 Feb;222:174-184. doi: 10.1016/j.ajo.2020.09.010. Epub 2020 Sep 15.
9
Oliver McFarlane syndrome and choroidal neovascularisation: a case report.
Ophthalmic Genet. 2020 Oct;41(5):451-456. doi: 10.1080/13816810.2020.1783689. Epub 2020 Jun 25.
10
A Family Affected by Novel C213W Mutation in PRPH2: Long-Term Follow-Up of CNV Secondary to Pattern Dystrophy.
Ophthalmic Surg Lasers Imaging Retina. 2020 Jun 1;51(6):354-362. doi: 10.3928/23258160-20200603-06.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验